9 – Lipid Mediators of Hypersensitivity and Inflammation

[1]  P. Netter,et al.  Cyclo-Oxygenase Isoenzymes , 1997, Drugs.

[2]  James G. Bollinger,et al.  Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model , 2007, The Journal of experimental medicine.

[3]  R. Proia,et al.  The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. , 2007, Immunity.

[4]  M. Beaven.  Division of labor: specialization of sphingosine kinases in mast cells. , 2007, Immunity.

[5]  G. FitzGerald,et al.  Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells , 2007, Journal of leukocyte biology.

[6]  Yeon-Joo Kang,et al.  Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. , 2007, Progress in lipid research.

[7]  J. M. Mathiesen,et al.  Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation , 2007, Respiratory research.

[8]  H. Hammad,et al.  Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells , 2007, The Journal of experimental medicine.

[9]  S. Payne,et al.  The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. , 2007, Blood.

[10]  G. FitzGerald,et al.  Prostaglandin I2 Analogs Inhibit Proinflammatory Cytokine Production and T Cell Stimulatory Function of Dendritic Cells1 , 2007, The Journal of Immunology.

[11]  B. Haribabu,et al.  Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. , 2007, Blood.

[12]  Edward A Dennis,et al.  The phospholipase A2 superfamily and its group numbering system. , 2006, Biochimica et biophysica acta.

[13]  M. Trincavelli,et al.  The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor , 2006, The EMBO journal.

[14]  D. Morgan,et al.  Cyclooxygenase-1 Overexpression Decreases Basal Airway Responsiveness but Not Allergic Inflammation1 , 2006, The Journal of Immunology.

[15]  Prostacyclin analogues: prevention of cardiovascular diseases. , 2006, Cardiovascular & hematological agents in medicinal chemistry.

[16]  Yongfeng Jiang,et al.  Cutting Edge: Interleukin 4-Dependent Mast Cell Proliferation Requires Autocrine/Intracrine Cysteinyl Leukotriene-Induced Signaling1 , 2006, The Journal of Immunology.

[17]  G. FitzGerald,et al.  COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[18]  W. Busse,et al.  Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[19]  S. Wenzel,et al.  Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. , 2006, The Journal of allergy and clinical immunology.

[20]  S. Abramson,et al.  Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. , 2006, Clinical immunology.

[21]  A. Togias,et al.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  Chunli Feng,et al.  Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. , 2006, Blood.

[23]  D. Friend,et al.  Cysteinyl Leukotrienes Regulate Th2 Cell-Dependent Pulmonary Inflammation1 , 2006, The Journal of Immunology.

[24]  M. Boothby,et al.  Oxidant stress modulates murine allergic airway responses. , 2006, Free radical biology & medicine.

[25]  E. Gelfand,et al.  The Leukotriene B4 Receptor (BLT1) Is Required for Effector CD8+ T Cell-Mediated, Mast Cell-Dependent Airway Hyperresponsiveness1 , 2006, The Journal of Immunology.

[26]  T. Scott,et al.  Positioning prostanoids of the D and J series in the immunopathogenic scheme. , 2006, Immunology letters.

[27]  Taro Yamada,et al.  Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. , 2006, Biochemistry.

[28]  C. Brander,et al.  The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. , 2006, Blood.

[29]  Garret A FitzGerald,et al.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. , 2005, The Journal of clinical investigation.

[30]  J. Boyce,et al.  Lysophospholipids as mediators of immunity. , 2006, Advances in immunology.

[31]  L. Audoly,et al.  Prostaglandin E2 protects lower airways against bronchoconstriction. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[32]  J. Morrow,et al.  Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent1 , 2005, The Journal of Immunology.

[33]  T. Brock.  Regulating leukotriene synthesis: The role of nuclear 5‐lipoxygenase , 2005, Journal of cellular biochemistry.

[34]  S. Narumiya,et al.  Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 , 2005, Nature Immunology.

[35]  T. Yagi,et al.  Absence of Leukotriene B4 Receptor 1 Confers Resistance to Airway Hyperresponsiveness and Th2-Type Immune Responses3 , 2005, The Journal of Immunology.

[36]  L. Palmer,et al.  Diminished lipoxin biosynthesis in severe asthma. , 2005, American journal of respiratory and critical care medicine.

[37]  B. Levy.  Lipoxins and lipoxin analogs in asthma. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[38]  R. Geha,et al.  COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. , 2005, The Journal of allergy and clinical immunology.

[39]  K. Rabe,et al.  Small airways function and molecular markers in exhaled air in mild asthma , 2005, Thorax.

[40]  P. Barnes,et al.  Exhaled 8-isoprostane in childhood asthma , 2005, Respiratory research.

[41]  E. Gelfand,et al.  Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness. , 2005, American journal of respiratory and critical care medicine.

[42]  A. Baatjes,et al.  Expression of functional cysteinyl leukotriene receptors by human basophils. , 2005, The Journal of allergy and clinical immunology.

[43]  T. Williams,et al.  Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors , 2005, The Journal of experimental medicine.

[44]  E. Gelfand,et al.  Leukotriene B4 Receptor-1 Is Essential for Allergen-Mediated Recruitment of CD8+ T Cells and Airway Hyperresponsiveness1 , 2005, The Journal of Immunology.

[45]  E. Dennis,et al.  Spinal phospholipase A2 in inflammatory hyperalgesia: role of Group IVA cPLA2 , 2005, British journal of pharmacology.

[46]  K. Rundell,et al.  Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise , 2005, British Journal of Sports Medicine.

[47]  S. Fleury,et al.  Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse 1 , 2005, The Journal of Immunology.

[48]  L. Wood,et al.  Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. , 2005, American journal of respiratory and critical care medicine.

[49]  K. Yamagata,et al.  Augmentation of allergic inflammation in the airways of cyclooxygenase‐2‐deficient mice , 2005, Respirology.

[50]  J. Rokach,et al.  Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE. , 2005, Progress in lipid research.

[51]  A. Lindqvist,et al.  Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. , 2005, The Journal of allergy and clinical immunology.

[52]  J. Morrow,et al.  Cyclooxygenase Inhibition Augments Allergic Inflammation through CD4-Dependent, STAT6-Independent Mechanisms1 , 2005, The Journal of Immunology.

[53]  E. Goetzl,et al.  Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. , 2004, The Journal of clinical investigation.

[54]  P. Montuschi,et al.  Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. , 2004, The Journal of allergy and clinical immunology.

[55]  N. Martinelli,et al.  Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. , 2004, The Journal of allergy and clinical immunology.

[56]  R. Breyer,et al.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.

[57]  Y. Kanaoka,et al.  Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses1 , 2004, The Journal of Immunology.

[58]  K. Ruan.  Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway. , 2004, Mini reviews in medicinal chemistry.

[59]  N. Méthot,et al.  Deletion of Microsomal Prostaglandin E2 (PGE2) Synthase-1 Reduces Inducible and Basal PGE2 Production and Alters the Gastric Prostanoid Profile* , 2004, Journal of Biological Chemistry.

[60]  Xin Lin,et al.  Cell signalling through thromboxane A2 receptors. , 2004, Cellular signalling.

[61]  R. Proia,et al.  Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis , 2004, The Journal of experimental medicine.

[62]  M. Idzko,et al.  Lysophosphatidic Acid Induces Chemotaxis, Oxygen Radical Production, CD11b Up-Regulation, Ca2+ Mobilization, and Actin Reorganization in Human Eosinophils via Pertussis Toxin-Sensitive G Proteins1 , 2004, The Journal of Immunology.

[63]  H. Hammad,et al.  Activation of the D Prostanoid Receptor 1 Regulates Immune and Skin Allergic Responses1 , 2004, The Journal of Immunology.

[64]  Y. Obase,et al.  Cysteinyl Leukotrienes Regulate Dendritic Cell Functions in a Murine Model of Asthma , 2004, The Journal of Immunology.

[65]  M. Corradi,et al.  Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. , 2004, The Journal of allergy and clinical immunology.

[66]  D. Kemeny,et al.  Inhibition of Th1- and Th2-Mediated Airway Inflammation by the Sphingosine 1-Phosphate Receptor Agonist FTY720 , 2003, The Journal of Immunology.

[67]  H. Hammad,et al.  Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 1 , 2003, The Journal of Immunology.

[68]  B. Vargaftig,et al.  Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[69]  S. Narumiya,et al.  Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. , 2003, American journal of respiratory cell and molecular biology.

[70]  J. Morrow,et al.  The isoprostanes: unique products of arachidonic acid oxidation-a review. , 2003, Current medicinal chemistry.

[71]  R. Gerszten,et al.  Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment , 2003, Nature Immunology.

[72]  M. Hatano,et al.  Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine , 2003, The Journal of experimental medicine.

[73]  B. L. Diaz,et al.  Phospholipase A(2). , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[74]  A. Tager,et al.  BLT1 and BLT2: the leukotriene B(4) receptors. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[75]  P. Montuschi,et al.  Increased exhaled 8-isoprostane in childhood asthma. , 2003, Chest.

[76]  D. Zeldin,et al.  Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. , 2003, American journal of respiratory and critical care medicine.

[77]  E. Baraldi,et al.  Treatment of concurrent OSA may benefit patients with heart failure , 2003, Thorax.

[78]  A. Hartnell,et al.  Δ12-Prostaglandin J2, a Plasma Metabolite of Prostaglandin D2, Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis1 , 2003, The Journal of Immunology.

[79]  B. Koller,et al.  Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[80]  B. Vargaftig,et al.  Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lungs. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[81]  G. O'neill,et al.  Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2 , 2002, British journal of pharmacology.

[82]  Z. Jaffar,et al.  A Key Role for Prostaglandin I2 in Limiting Lung Mucosal Th2, But Not Th1, Responses to Inhaled Allergen1 , 2002, The Journal of Immunology.

[83]  P. O'Byrne,et al.  Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. , 2002, American journal of respiratory and critical care medicine.

[84]  S. Narumiya,et al.  Augmentation of allergic inflammation in prostanoid IP receptor deficient mice , 2002, British journal of pharmacology.

[85]  Z. Erbagci.  The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. , 2002, The Journal of allergy and clinical immunology.

[86]  Eugene Y. Kim,et al.  Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.

[87]  Takao Shimizu,et al.  Roles for cytosolic phospholipase A2α as revealed by gene-targeted mice , 2002 .

[88]  K. Austen,et al.  Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. , 2002, Prostaglandins & other lipid mediators.

[89]  P. Montuschi,et al.  Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. , 2002, American journal of respiratory and critical care medicine.

[90]  Z. Ungvari,et al.  Oxidative stress-induced isoprostane formation may contribute to aspirin resistance in platelets. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[91]  Y. Ouchi,et al.  A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis , 2002, Nature Medicine.

[92]  Yin Tintut,et al.  8-Isoprostaglandin E2 Enhances Receptor-activated NFκB Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway* , 2002, The Journal of Biological Chemistry.

[93]  J. Morrow,et al.  Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. , 2002, American journal of respiratory and critical care medicine.

[94]  S. Holgate,et al.  Role of cysteinyl leukotrienes in adenosine 5`-monophosphate induced bronchoconstriction in asthma , 2002, Thorax.

[95]  Yoshihiro Urade,et al.  Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice1 , 2002, The Journal of Immunology.

[96]  E. Chi,et al.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. , 2002, American journal of respiratory and critical care medicine.

[97]  G. O'neill,et al.  Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. , 2001, The Journal of allergy and clinical immunology.

[98]  D. Schwartz,et al.  Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. , 2001, American journal of respiratory cell and molecular biology.

[99]  R. Corrocher,et al.  Efficacy of leukotriene receptor antagonist in chronic urticaria. A double‐blind, placebo‐controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[100]  M. Diamond,et al.  Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. , 2001, Blood.

[101]  J. Schroeder,et al.  Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. , 2001, The Journal of allergy and clinical immunology.

[102]  M. Breyer,et al.  Physiological regulation of cyclooxygenase-2 in the kidney. , 2001, American journal of physiology. Renal physiology.

[103]  S. Anderson,et al.  Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. , 2001, American journal of respiratory and critical care medicine.

[104]  S. Spiegel,et al.  Sphingosine 1‐phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[105]  P. Howarth,et al.  Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. , 2001, Thorax.

[106]  T. Evans,et al.  Characterization of the effects of isoprostanes on platelet aggregation in human whole blood , 2001, British journal of pharmacology.

[107]  J. Morrow,et al.  Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2‐isoprostane, 15‐F2t‐IsoP (8‐iso‐PGF2α) , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[108]  K. Sugamura,et al.  Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2 , 2001, The Journal of experimental medicine.

[109]  K. Austen,et al.  T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. , 2001 .

[110]  M. Yacoub,et al.  Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells , 2001 .

[111]  R. Breyer,et al.  G protein-coupled prostanoid receptors and the kidney. , 2001, Annual review of physiology.

[112]  R. Breyer,et al.  Prostanoid receptors: subtypes and signaling. , 2001, Annual review of pharmacology and toxicology.

[113]  K. Gomi,et al.  Prostaglandin E2 Selectively Enhances the IgE-Mediated Production of IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor by Mast Cells Through an EP1/EP3-Dependent Mechanism1 , 2000, The Journal of Immunology.

[114]  Makoto Murakami,et al.  Molecular Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2Biosynthesis* , 2000, The Journal of Biological Chemistry.

[115]  Makoto Murakami,et al.  Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[116]  K. Ishimura,et al.  Immunocytochemical localization of lung-type prostaglandin F synthase in the rat spinal cord , 2000, Brain Research.

[117]  B. Graham,et al.  Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. , 2000, American journal of respiratory and critical care medicine.

[118]  J. Murray,et al.  Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. , 2000, American journal of respiratory and critical care medicine.

[119]  J. Oates,et al.  EP2 receptor mediates bronchodilation by PGE2 in mice , 2000 .

[120]  P. Kalinski,et al.  Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1 , 2000, The Journal of Immunology.

[121]  R. Breyer,et al.  Structure‐Function Analyses of Eicosanoid Receptors: Physiologic and Therapeutic Implications , 2000, Annals of the New York Academy of Sciences.

[122]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[123]  M. Nishizawa,et al.  cDNA cloning, expression and characterization of human prostaglandin F synthase 1 , 1999 .

[124]  I. Pavord,et al.  Induced sputum eicosanoid concentrations in asthma. , 1999, American journal of respiratory and critical care medicine.

[125]  M. Szmidt,et al.  A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma. , 1999, Thorax.

[126]  M. Fresno,et al.  Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. , 1999, Journal of immunology.

[127]  P. Thompson,et al.  PGE 2 and dibutyryl cyclic adenosine monophosphate prolong eosinophil survival in vitro. , 1999, The Journal of allergy and clinical immunology.

[128]  S. Kelsen,et al.  Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells. , 1999, The Journal of allergy and clinical immunology.

[129]  M. Hoshino,et al.  Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma. , 1999, The Journal of allergy and clinical immunology.

[130]  L. Spain,et al.  Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. , 1999, The Journal of clinical investigation.

[131]  Lynn Wei,et al.  Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.

[132]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[133]  P. O'Byrne,et al.  Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[134]  K. Chung,et al.  Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. , 1998, American journal of respiratory and critical care medicine.

[135]  O. Elbek,et al.  Misoprostol has no favorable effect on bronchial hyperresponsiveness in mild asthmatics. , 1998, Allergie et immunologie.

[136]  K. Racké,et al.  Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3H]acetylcholine release from isolated human bronchi , 1998, British journal of pharmacology.

[137]  S. Fukuyama,et al.  Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[138]  R. Robertson,et al.  Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. , 1998, Diabetes.

[139]  J. Morrow,et al.  A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2α on retinal vessels. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[140]  N. Kohno,et al.  Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice. , 1998, The European respiratory journal.

[141]  H. Seyberth,et al.  Localization of the prostacyclin receptor in human kidney. , 1998, Kidney international.

[142]  H. Boushey,et al.  The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma. , 1997, American journal of respiratory and critical care medicine.

[143]  A. Sousa,et al.  Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. , 1997, Thorax.

[144]  H. Sinzinger,et al.  Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics. , 1997, Lymphology.

[145]  S. Zahler,et al.  Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts. , 1997, Journal of cardiovascular pharmacology.

[146]  J. Sheller,et al.  5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. , 1997, The American journal of physiology.

[147]  A. Knox,et al.  Effect of interleukin‐1β, tumour necrosis factor‐α and interferon‐γ on the induction of cyclo‐oxygenase‐2 in cultured human airway smooth muscle cells , 1997 .

[148]  M. Teixeira,et al.  Characterization of the prostanoid receptors mediating inhibition of PAF‐induced aggregation of guinea‐pig eosinophils , 1997, British journal of pharmacology.

[149]  R. Dworski,et al.  Differential sensitivities of human blood monocytes and alveolar macrophages to the inhibition of prostaglandin endoperoxide synthase-2 by interleukin-4. , 1997, Prostaglandins.

[150]  E. Ellis,et al.  Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. , 1997, Stroke.

[151]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human gastric carcinoma. , 1997, Cancer research.

[152]  J. Bousquet,et al.  Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. , 1997, American journal of respiratory and critical care medicine.

[153]  M. Yacoub,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type , 1997, British journal of pharmacology.

[154]  P. Worley,et al.  Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome , 1997, Brain and Development.

[155]  I. Adcock,et al.  Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. , 1996, Life sciences.

[156]  D. Harry,et al.  8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats. , 1997, Gastroenterology.

[157]  E. Chi,et al.  The importance of leukotrienes in airway inflammation in a mouse model of asthma , 1996, The Journal of experimental medicine.

[158]  J. Drazen,et al.  Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. , 1996, The American journal of physiology.

[159]  K. Austen,et al.  Molecular cloning of the gene for human leukotriene C4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35. , 1996, The Journal of biological chemistry.

[160]  E. Israel,et al.  Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. , 1996, JAMA.

[161]  J. Adams,et al.  Constitutive cyclooxygenase (COX‐1) and inducible cyclooxygenase (COX‐2): Rationale for selective inhibition and progress to date , 1996, Medicinal research reviews.

[162]  S. Narumiya,et al.  Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. , 1996, The Journal of clinical investigation.

[163]  R. M. Refini,et al.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.

[164]  J. Murray,et al.  A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. , 1996, The Journal of allergy and clinical immunology.

[165]  K. Furusho,et al.  Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. , 1995, Journal of immunology.

[166]  C. P. Green,et al.  Persistent increase in plasma and urinary leukotrienes after acute asthma. , 1995, Archives of disease in childhood.

[167]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[168]  J. Evans,et al.  Cloning and characterization of the human leukotriene A4 hydrolase gene. , 1995, European journal of biochemistry.

[169]  S. Narumiya,et al.  Identification of prostaglandin E receptor ‘EP2’ cloned from mastocytoma cells as EP4 subtype , 1995, FEBS letters.

[170]  P. O'Byrne,et al.  Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. , 1995, Journal of immunology.

[171]  P. Howarth,et al.  Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. , 1995, The European respiratory journal.

[172]  S. Yamamoto,et al.  Induction of cyclooxygenase-2 is responsible for interleukin-1 beta-dependent prostaglandin E2 synthesis by human lung fibroblasts. , 1995, American journal of respiratory cell and molecular biology.

[173]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[174]  R. V. van Neerven,et al.  Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin‐2 , 1995, European journal of immunology.

[175]  K. Kent,et al.  Additions and Corrections to Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. , 1994, The Journal of Biological Chemistry.

[176]  K. Badr,et al.  Stimulatory Effect of 8‐Epi-PGF2α, An F2-Isoprostane, on Endothelin‐1 Release , 1995 .

[177]  J. Vane,et al.  Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone , 1994, British journal of pharmacology.

[178]  S. Bandoh,et al.  Characterization of the human gene (TBXAS1) encoding thromboxane synthase. , 1994, European journal of biochemistry.

[179]  G. Freeman,et al.  Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[180]  S. Narumiya,et al.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. , 1994, Pharmacological reviews.

[181]  P. O'Byrne,et al.  Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. , 1994, American journal of respiratory and critical care medicine.

[182]  I. Pavord,et al.  Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo‐oxygenase inhibitors , 1994, British journal of pharmacology.

[183]  J. Oates,et al.  Effect of oral prednisone on airway inflammatory mediators in atopic asthma. , 1994, American journal of respiratory and critical care medicine.

[184]  Y. Boie,et al.  Cloning and expression of three isoforms of the human EP3 prostanoid receptor , 1994, FEBS letters.

[185]  E. Goetzl,et al.  Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2. , 1993, Biochemical and biophysical research communications.

[186]  G. FitzGerald,et al.  Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. , 1993, The Journal of biological chemistry.

[187]  W. Busse,et al.  The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.

[188]  K. Badr,et al.  Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane. , 1993, Biochemical and biophysical research communications.

[189]  I. Pavord,et al.  Effect of inhaled prostaglandin E2 on allergen-induced asthma. , 1993, The American review of respiratory disease.

[190]  P. Kalinski,et al.  Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. , 1993, Journal of immunology.

[191]  J. Morrow,et al.  Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. , 1993, The American journal of physiology.

[192]  J. Morrow,et al.  Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung. , 1993, Journal of applied physiology.

[193]  B. C. Chin,et al.  Prostaglandins inhibit inflammatory mediator release from rat mast cells. , 1993, Gastroenterology.

[194]  J. Morrow,et al.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. , 1992, The Journal of clinical investigation.

[195]  D. Broide,et al.  Cytokines in symptomatic asthma airways. , 1992, The Journal of allergy and clinical immunology.

[196]  C. O’Callaghan,et al.  Respiratory status and allergy after bronchiolitis. , 1992, Archives of disease in childhood.

[197]  W. Busse,et al.  Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.

[198]  E. Bleecker,et al.  Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. , 1991, The American review of respiratory disease.

[199]  H. Kita,et al.  Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate. , 1991, Journal of immunology.

[200]  A. Kagey‐Sobotka,et al.  Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. , 1991, Journal of immunology.

[201]  M. Fujimura,et al.  Effect of oral administration of a prostacyclin analog (OP-41483) on pulmonary function and bronchial responsiveness in stable asthmatic subjects. , 1991, The Journal of asthma : official journal of the Association for the Care of Asthma.

[202]  C. Dollery,et al.  Thromboxane A2 biosynthesis in acute asthma and after antigen challenge. , 1991, The American review of respiratory disease.

[203]  M. Betz,et al.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.

[204]  W. Doyle,et al.  Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. , 1990, The Journal of allergy and clinical immunology.

[205]  E. Bleecker,et al.  Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. , 1990, The American review of respiratory disease.

[206]  S. Marney,et al.  Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. , 1990, The American review of respiratory disease.

[207]  A. Kagey‐Sobotka,et al.  Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. , 1990, The Journal of allergy and clinical immunology.

[208]  D. Woodward,et al.  Studies on the ocular pharmacology of prostaglandin D2. , 1990, Investigative ophthalmology & visual science.

[209]  G. FitzGerald,et al.  Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. , 1989, The American review of respiratory disease.

[210]  J. Nadel,et al.  Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. , 1989, Journal of applied physiology.

[211]  J. Resau,et al.  Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. , 1989, The American review of respiratory disease.

[212]  P. O'Byrne,et al.  Effect of indomethacin on allergen-induced asthmatic responses. , 1989, Journal of applied physiology.

[213]  J. Drazen,et al.  Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.

[214]  S. Holgate,et al.  Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. , 1988, Journal of applied physiology.

[215]  L. Lichtenstein,et al.  Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. , 1988, Journal of immunology.

[216]  J. Nadel,et al.  The effects of epithelial cell supernatant on contractions of isolated canine tracheal smooth muscle. , 1988, The American review of respiratory disease.

[217]  R. Naclerio,et al.  Mediator release after nasal airway challenge with allergen. , 2015, The American review of respiratory disease.

[218]  A. Szczeklik,et al.  Lack of effect of i.v. prostacyclin on aspirin-induced asthma. , 1986, European journal of respiratory diseases.

[219]  P. O'Byrne,et al.  The effect of indomethacin on exercise-induced bronchoconstriction and refractoriness after exercise. , 1986, The American review of respiratory disease.

[220]  H. Boushey,et al.  O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. , 1986, Journal of applied physiology.

[221]  S. Holgate,et al.  Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects. , 2015, The American review of respiratory disease.

[222]  P. O'Byrne,et al.  Leukotriene B4 induces airway hyperresponsiveness in dogs. , 1985, Journal of applied physiology.

[223]  H. Bisgaard,et al.  Production of Leukotrienes in Human Skin and Conjunctival Mucosa after Specific Allergen Challenge , 1985, Allergy.

[224]  E. Shephard,et al.  Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment. , 1985, British journal of clinical pharmacology.

[225]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[226]  F. Fitzpatrick,et al.  Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. , 1983, The Journal of biological chemistry.

[227]  S. Moncada,et al.  Pharmacological interactions between prostacyclin and thromboxanes. , 1983, British medical bulletin.

[228]  E. Schulman,et al.  Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[229]  J. Fish,et al.  Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. , 2015, The American review of respiratory disease.

[230]  F. Fitzpatrick,et al.  Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. , 1981, The American review of respiratory disease.

[231]  Robert A. Lewis,et al.  Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds , 1981, Nature.

[232]  J. Oates,et al.  Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.

[233]  M. Robuschi,et al.  Effects of prostacyclin on aspecifically and specifically induced bronchoconstriction in asthmatic patients. , 1980, European journal of respiratory diseases. Supplement.

[234]  M. Robuschi,et al.  Effect of prostacyclin on antigfn inducfd ifowdiatf rronchoconstriction in astmatic patients , 1979 .

[235]  J. Oates,et al.  Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite. , 1977, The Journal of biological chemistry.

[236]  R. J. Flower,et al.  INFLAMMATORY EFFECTS OF PROSTAGLANDIN D2 IN RAT AND HUMAN SKIN , 1976, British journal of pharmacology.

[237]  A. Smith,et al.  Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man. , 1975, Clinical science and molecular medicine.

[238]  M. Kaliner,et al.  Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. , 1974, Journal of immunology.

[239]  P. Hedqvist,et al.  Bronchial Hyperreactivity to Prostaglandin F2α and Histamine in Patients with Asthma , 1973, British medical journal.

[240]  A. Smith,et al.  Prostaglandins and resistance to beta adrenoceptor stimulants. , 1972, British medical journal.

[241]  E. R. Trethewie,et al.  THE LIBERATION OF A SLOW‐REACTING SMOOTH MUSCLE‐STIMULATING SUBSTANCE IN ANAPHYLAXIS , 1940 .